Blue light surgery may slash bladder cancer recurrence

NCT ID NCT06525571

Recruiting now Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using blue light during bladder tumor removal surgery helps surgeons see and remove more cancer than standard white light. About 200 adults with high-risk non-muscle invasive bladder cancer will be randomly assigned to one of the two methods. The goal is to see if blue light reduces leftover cancer and lowers the chance of the cancer coming back.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

Johns Hopkins University School of Medicine
RECRUITING

Baltimore, Maryland, 21287, United States
Sibley Memorial Hospital
RECRUITING

Washington D.C., District of Columbia, 20016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.